4//SEC Filing
GARRITY THOMAS J 4
Accession 0001209191-21-003497
CIK 0001016169other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 8:21 PM ET
Size
14.3 KB
Accession
0001209191-21-003497
Insider Transaction Report
Form 4
GARRITY THOMAS J
Director
Transactions
- Sale
Common Stock
2021-01-11$4.07/sh−20,000$81,400→ 224,406 total - Exercise/Conversion
Common Stock
2021-01-11$1.12/sh+50,000$56,000→ 274,406 total - Sale
Common Stock
2021-01-11$4.05/sh−50,000$202,500→ 224,406 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-11−20,000→ 0 totalExercise: $2.24Exp: 2021-09-09→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2021-01-11$2.24/sh+20,000$44,800→ 244,406 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-11−50,000→ 0 totalExercise: $1.12Exp: 2026-06-02→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The options vested and became exercisable in four equal quarterly installments from the grant date of September 9, 2011.
- [F3]The options vested and became exercisable in four equal quarterly installments from the grant date of June 2, 2016.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001275012
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 8:21 PM ET
- Size
- 14.3 KB